Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Revcovi for the Treatment of ADA-SCID

Drug Name

Revcovi (elapegademase-lvlr)

Developer

Leadiant Biosciences (formerly Sigma-Tau Pharmaceuticals)

Therapy Class

Enzyme replacement therapy

Product Description

PEGylated recombinant adenosine deaminase (rADA) enzyme

Current Indication

Adenosine deaminase severe combined immune deficiency

Market Sector

Immunology

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top